Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT03123211
What this trial is testing

Expanded Access to Veliparib

Who this might be right for
Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically SoundTriple Negative Breast Cancer (TNBC)High Grade Serous Ovarian Cancer+1 more
AbbVie
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743632
What this trial is testing

Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC

Who this might be right for
Breast CancerTriple Negative Breast Cancer
University of Kansas Medical Center 110
Testing effectiveness (Phase 2)Study completedNCT00894504
What this trial is testing

Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
SCRI Development Innovations, LLC 71
Early research (Phase 1)Looking for participantsNCT07178171
What this trial is testing

QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC

Who this might be right for
TNBC, Triple Negative Breast Cancer
Xijing Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01969032
What this trial is testing

Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Russian Academy of Medical Sciences 41
Early research (Phase 1)Active Not RecruitingNCT05339685
What this trial is testing

BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors

Who this might be right for
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 82
Testing effectiveness (Phase 2)Looking for participantsNCT04677816
What this trial is testing

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Who this might be right for
Triple Negative Breast CancerVitamin D DeficiencyInvasive Breast Cancer
Wake Forest University Health Sciences 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05455658
What this trial is testing

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8+14 more
University of Washington 33
Testing effectiveness (Phase 2)Study completedNCT02632448
What this trial is testing

LY2880070 in Participants With Advanced or Metastatic Cancer

Who this might be right for
Solid TumorsColorectal CancerBreast Cancer+9 more
Esperas Pharma Inc. 229
Early research (Phase 1)Study completedNCT05712889
What this trial is testing

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 29
Testing effectiveness (Phase 2)Ended earlyNCT02368691
What this trial is testing

Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)

Who this might be right for
Triple Negative Breast Cancer
GTx 32
Not applicableLooking for participantsNCT06700382
What this trial is testing

Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC

Who this might be right for
Triple Negative Breast Cancer
Shu Wang 1,166
Not applicableActive Not RecruitingNCT04068623
What this trial is testing

Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Centre Jean Perrin 90
Testing effectiveness (Phase 2)Looking for participantsNCT06797635
What this trial is testing

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

Who this might be right for
Breast NeoplasmsBreast Cancer
Merck Sharp & Dohme LLC 372
Testing effectiveness (Phase 2)Ended earlyNCT04789668
What this trial is testing

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Hematopoietic and Lymphoid Cell Neoplasm+11 more
M.D. Anderson Cancer Center 8
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Not applicableLooking for participantsNCT06225505
What this trial is testing

Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)

Who this might be right for
Triple Negative Breast Cancer
Institut Curie 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT03546686
What this trial is testing

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 51
Early research (Phase 1)Active Not RecruitingNCT05358639
What this trial is testing

Combination of Olaparib and Navitoclax in Women with HGSC and TNBC

Who this might be right for
High Grade Serous CarcinomaTriple Negative Breast CancerOvarian Cancer
Sunnybrook Health Sciences Centre 36
Testing effectiveness (Phase 2)Looking for participantsNCT01042379
What this trial is testing

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+8 more
QuantumLeap Healthcare Collaborative 5,000
Next Page